University of Vermont

College of Medicine

Research

Success in competitive funding environment

  • In 2013, College of Medicine funding represented nearly 64% of total research funding at UVM.
  • A total of 308 research projects were funded at the College of Medicine in 2013.
education University of Vermont College of Medicine

Research News

In 2013, the UVM College of Medicine received nearly $68 million in research funding, representing nearly 64 percent of total research funding at the University. Principal investigators led more than 300 funded projects in the basic, clinical and translational sciences, advancing our reputation for outstanding science and discovery.

Jos Van Der Velden, Ph.D., University of Vermont Assistant Professor of Pathology and member of the Vermont Cancer Center at UVM/Fletcher Allen

Van Der Velden’s Lung Cancer Research Earns Francis B. Parker Fellowship

Jos Van Der Velden, Ph.D., University of Vermont assistant professor of pathology and a member of the Vermont Cancer Center at UVM/Fletcher Allen, has been named to the 2014 class of Francis B. Parker Fellows in recognition of his research focused on non-small cell lung cancer (NSCLC). 

Full Story >>

Rodney Parsons, Ph.D., Professor of Neurological Sciences Emeritus

Parsons’ Shared Instrumentation Grant Increases Capabilities of Neuroscience Imaging Core

The University of Vermont College of Medicine’s Neuroscience Center of Biomedical Research Excellence-supported Imaging/Physiology Core is getting a new microscope – specifically, a Yokogawa CSU-W1 spinning disk confocal microscopy system. The system comes via a $500,000 dollar National Institutes of Health (NIH) Shared ...

Full Story >>

Laurie Whittaker Leclair, M.D., UVM Associate Professor of Medicine, right, serves as Director of the Adult Cystic Fibrosis Center at Fletcher Allen Health Care.

Leclair Comments on Phase 3 Cystic Fibrosis Treatment Clinical Trial Results

Life is short for patients with cystic fibrosis (CF), but not as short as it used to be. In fact, lifetime survival for individuals afflicted with the inherited disease – caused by a single defective gene – has improved drastically since the 1950s when most died during childhood, due to the development of more effective ...

Full Story >>

View all College of Medicine Research News

View all University of Vermont News